For the quarter ending 2025-09-30, AXGN had $1,866K increase in cash & cash equivalents over the period. $1,703K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | 708 | -3,255 |
| Depreciation | 1,642 | 3,385 |
| Amortization of right-of-use assets | 110 | 184 |
| Amortization of intangible assets | 88 | 133 |
| Amortization of debt discount and deferred financing fees | 224 | 442 |
| Provision for bad debts | -28 | 386 |
| Change in fair value of debt derivative liabilities | 209 | 322 |
| Investment gains | 117 | 121 |
| Stock-based compensation | 5,424 | 8,077 |
| Accounts receivable | 2,718 | 4,310 |
| Inventory | 3,807 | 3,591 |
| Prepaid expenses and other assets | 538 | 81 |
| Accounts payable and accrued expenses | 2,770 | -5,755 |
| Operating lease obligations | -291 | -542 |
| Cash paid for interest portion of financing lease obligations | 1 | 2 |
| Other long-term liabilities | -34 | -77 |
| Net cash used in operating activities | 3,223 | -5,449 |
| Purchase of property and equipment | 1,520 | 978 |
| Purchase of investments | 5,886 | 7,837 |
| Proceeds from sale of investments | 4,000 | 4,000 |
| Cash payments for intangible assets | 345 | 793 |
| Net cash used in investing activities | -3,751 | -5,608 |
| Cash paid for debt portion of financing lease obligations | 3 | 8 |
| Proceeds from exercise of stock options and espp stock purchases | 2,397 | 3,547 |
| Net cash provided by financing activities | 2,394 | 3,539 |
| Net decrease in cash and cash equivalents, and restricted cash | 1,866 | -7,518 |
| Cash and cash equivalents at beginning of period | 33,554 | - |
| Cash and cash equivalents at end of period | 27,902 | - |
Axogen, Inc. (AXGN)
Axogen, Inc. (AXGN)